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Primate TNF Promoters Reveal Markers of Phylogeny and
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Gagneux5, Stephen J. O’Brien6, Oliver A. Ryder7,8, Anne E. Goldfeld1*
1 The CBR Institute for Biomedical Research, Harvard Medical School, Boston, Massachusetts, United States of America, 2Gibbon Conservation Center,
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Rehabilitacio´n de Animales Silvestres, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional de Colombia, Bogota´, Colombia, 5Project
for Explaining the Origin of Humans, Glycobiology Research and Training Center, Department of Medicine and Cellular and Molecular Medicine,
University of California at San Diego, La Jolla, California, United States of America, 6 Laboratory of Genomic Diversity, National Cancer Institute,
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Background. Tumor necrosis factor (TNF) is a critical cytokine in the immune response whose transcriptional activation is
controlled by a proximal promoter region that is highly conserved in mammals and, in particular, primates. Specific single
nucleotide polymorphisms (SNPs) upstream of the proximal human TNF promoter have been identified, which are markers of
human ancestry. Methodology/Principal findings. Using a comparative genomics approach we show that certain fixed
genetic differences in the TNF promoter serve as markers of primate speciation. We also demonstrate that distinct alleles of
most human TNF promoter SNPs are identical to fixed nucleotides in primate TNF promoters. Furthermore, we identify fixed
genetic differences within the proximal TNF promoters of Asian apes that do not occur in African ape or human TNF promoters.
Strikingly, protein-DNA binding assays and gene reporter assays comparing these Asian ape TNF promoters to African ape and
human TNF promoters demonstrate that, unlike the fixed differences that we define that are associated with primate
phylogeny, these Asian ape-specific fixed differences impair transcription factor binding at an Sp1 site and decrease TNF
transcription induced by bacterial stimulation of macrophages. Conclusions/significance. Here, we have presented the
broadest interspecies comparison of a regulatory region of an innate immune response gene to date. We have characterized
nucleotide positions in Asian ape TNF promoters that underlie functional changes in cell type- and stimulus-specific activation
of the TNF gene. We have also identified ancestral TNF promoter nucleotide states in the primate lineage that correspond to
human SNP alleles. These findings may reflect evolution of Asian and African apes under a distinct set of infectious disease
pressures involving the innate immune response and TNF.
Citation: Baena A, Mootnick AR, Falvo JV, Tsytskova AV, Ligeiro F, et al (2007) Primate TNF Promoters Reveal Markers of Phylogeny and Evolution of
Innate Immunity. PLoS ONE 2(7): e621. doi:10.1371/journal.pone.0000621
INTRODUCTION
The gene encoding tumor necrosis factor (TNF), a cytokine that
plays a critical role in lymphocyte biology and in the innate and
adaptive immune response, is transcribed rapidly and to high
levels in response to multiple stimuli. This process is directed by
the formation of inducer-specific nucleoprotein complexes, known
as enhanceosomes, over a region of approximately 200 base pairs
upstream of the start site of transcription [1–4]. The non-coding
DNA elements within the TNF promoter that control stimulus-
specific transcription of the TNF gene, and the recruitment of
their cognate transcription factors, have been extensively charac-
terized [1–7], which provides an opportunity to examine these
functional regions across closely related species. Indeed, in an
earlier study, sequence comparisons among representative primate
species, including New World monkeys, revealed regions of
complete sequence conservation, or ‘‘phylogenetic footprints
[8],’’ from positions 2131 to 263 and 253 and 245 relative to
the start site of TNF gene transcription (Figure 1), in the core
region of the enhanceosome [9]. By contrast, sequences outside of
transcriptionally important regions showed high variability [9].
The human TNF gene is located within the most polymorphic
region of the human genome, the major histocompatibility
complex (MHC) region of chromosome 6, which includes the
human leukocyte antigen (HLA) genes [10]. At least ten common
single nucleotide polymorphisms (SNPs) have been identified in
the human TNF promoter, all of which fall outside of the
identified TNF primate phylogenetic footprints [11–19], a feature
consistent with the accrual of mutations under neutral evolution
[9,20]. In fact, several of the these TNF promoter SNPs have been
shown to be in non-random association with extended HLA
haplotypes [16,17,19,21], which are conserved blocks of DNA
sequences at the MHC locus between HLA-B and HLA-DR on
chromosome 6, where the TNF gene is located [22,23].
Since TNF promoter SNPs were first described, multiple
laboratories have studied their association with susceptibility to
autoimmune and infectious diseases. Although statistical associa-
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tions with a variety of diseases have been found in some studies,
there has been no consistent functional role demonstrated for any
TNF promoter SNP in the regulation of the TNF gene itself [24–
28]. Rather, these SNPs have been shown to be markers of human
ethnic diversity [19] and are likely markers for HLA or for other
genes yet to be identified that are involved in disease susceptibility
in different human ethnic groups [17,19]. By contrast, through
detailed examination of 411 TNF promoters from individuals of
distinct ethnic backgrounds, we demonstrated that the 200 bp
proximal promoter involved in the regulation of the gene is
completely conserved in humans, and defined the canonical
human TNF promoter sequence up to approximately 1.2 kb
relative to the transcription start site [17,19,29].
Here, we have undertaken one of the most broadly inclusive
analyses to date of a mammalian gene regulatory region, as well as
the broadest examination of the promoter region of an innate
immune response gene, across primate species. Specifically, we
isolated and sequenced approximately 1.2 kb of the upstream
promoter region of the TNF gene from 29 non-human primate
species and subspecies. These included multiple individuals
representing all species of the great apes [bonobo (Pan paniscus),
chimpanzee (Pan troglodytes), gorilla (Gorilla), and orangutan (Pongo)],
all four genera of gibbon (Hylobatidae), and multiple species of
Old World monkeys (OWM) and New World monkeys (NWM)
(Figure 2).
Using a comparative genomics approach, we found a total of
332 fixed differences from the consensus human TNF promoter
sequence in the primate species examined. We show that 41 of
these fixed genetic differences serve as markers of primate species
and subspecies. Strikingly, the monoallelic or biallelic variants
carried in multiple human TNF promoter SNPs match divergent
sequences in the primate lineage. In fact, the rare alleles found in
two human SNPs (21030 T/C and 2375 G/A) are identical to
TNF promoter sequences found at the same position in the New
World monkey clade, which diverged from the common ancestor
of other primates roughly 35 million years ago.
We also identified fixed differences unique to TNF promoters
from the Asian apes in an Sp1 site that lies 2173 to 2163 nt
relative to the start site of transcription of the human TNF
promoter. We have previously shown that this Sp1 site is involved
in the regulation of the human TNF gene in macrophages in
response to stimulation with lipopolysaccharide (LPS), a cell wall
component of gram-negative bacteria, or to Mycobacterium
tuberculosis (MTb) stimulation, but that this site is not required
for human TNF gene regulation in T cells stimulated via antigen
receptor engagement or calcium influx [3,4]. These data are
consistent with the cell type- and inducer-specific regulation of the
TNF gene [1–7].
Remarkably, here we show that these Asian ape-specific fixed
genetic differences impair binding of Sp1 and Sp3 proteins to the
site and decrease the relative level of TNF gene transcription in
response to LPS and MTb as compared to the human or African
ape TNF promoters. By contrast, these changes have no impact on
the regulation of the gene in T cells by calcium influx, consistent
with previous studies of the effects of specific mutations in this
site in stimulus-specific regulation of the human TNF gene
promoter. Thus, we provide evidence for adaptive changes in
an innate immune response gene correlated with the current
geographic distribution of higher primates. Furthermore, we
demonstrate that fixed nucleotide differences and polymorphisms
in the TNF promoter serve as markers of primate ancestry and
biodiversity.
Figure 1. The human TNF gene promoter. The sequence of the human TNF promoter from 2200 to +1 nt relative to the start site of transcription is
shown, along with previously identified phylogenetic footprints [9] and binding sites for the indicatedtranscription factors, including sites identified
as binding sites for multiple factors (crosshatched) in quantitative DNase I footprinting assays, by EMSA analysis, and by chromatin
immunoprecipitation assays [1–7]. The sequence of the upstream Sp1 site (upSp1) found in the indicated genera and species is shown, with
fixed nucleotide differences from the human sequence indicated in red. The thymine at position 29, which is invariant in all non-human primates
studied previously [9] and in this study, is also shown in red.
doi:10.1371/journal.pone.0000621.g001
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RESULTS
Fixed differences in the TNF promoter mark primate
phylogeny
We obtained blood, cell lines, or DNA samples from multiple
animals representing African and Asian ape species and sub-
species. Specifically, we obtained samples from the bonobo (Pan
paniscus); the chimpanzee (Pan troglodytes), including the four
subspecies of chimpanzee; the two species of gorilla, the western
(Gorilla gorilla) and the eastern (Gorilla beringei) gorilla; the two
species of orangutan, the Bornean (Pongo pygmaeus) and the
Sumatran (Pongo abelii) orangutan; and seven gibbon species
representing all four genera of gibbon [the lar gibbon (Hylobates
lar), the agile gibbon (Hylobates agilis), the Javan gibbon (Hylobates
moloch), the pileated gibbon (Hylobates pileatus), the eastern hoolock
gibbon (Hoolock leuconedys), the siamang (Symphalangus syndactylus),
and the northern white-cheeked gibbon (Nomascus l. leucogenys)]. We
also obtained samples from several species of African and Asian
OWM and NWM (Figure 2).
Approximately 1.2 kb of the TNF promoter was sequenced for
each sample, and the sequences corresponding to positions 21153
to +69 nt relative to the start site of transcription in the human
TNF promoter were aligned (Figure S1) and analyzed. Using the
mouse TNF promoter sequence as the outgroup, we performed
phylogenetic analyses and obtained very strong bootstrap values
for the nodes of divergence of the genera using neighbor joining
methods based on genetic distances (Kimura 2-parameter model)
as well as maximum parsimony (Figure 3). The species fell into
clear OWM (Chlorocebus, Cercopithecus, Cercocebus, Papio, Macaca) and
NWM (Ateles, Lagothrix, Cebus, Saimiri, Aotus) clades, similar to the
OWM and NWM groups observed in the analysis of genetic
distances based on the promoter or open reading frame of the CC
chemokine receptor 5 (CCR5) gene [30]. It is interesting to note
that the coding region of the TNF gene, which exhibits up to 99%
nucleotide sequence homology between humans and primate
species of the Papio, Macaca, Cercocebus, Saimiri, and Aotus genera
[31–35] exhibited Papio-Macaca and Saimiri-Aotus clades in
a Kimura 2-parameter analysis of genetic distances [35] consistent
with the OWM and NWM split we observe with the 59 non-coding
regions.
In general, the majority of gene sequences previously analyzed
in hominids supports a chimpanzee-human clade, although
a smaller proportion of the analyzed genes is consistent with
a chimpanzee-gorilla or human-gorilla clade [36–40]. Interesting-
ly, in the case of the TNF promoter, both approaches to
phylogenetic inference that we utilized (neighbor joining and
maximum parsimony) yield a bonobo-human clade, as well as
a chimpanzee-gorilla clade (Figure 3). Similarly, our phylogenetic
analyses yield a gibbon-orangutan clade, while evolutionary
relationships place orangutans in a hominid clade with great apes
and humans [41–43]. These observations indicate that sequence
conservation among primate TNF promoters can reflect homo-
Figure 2. Primate species examined in this study. The common and taxonomic designation for each species or subspecies [110,111], number of
individuals from which DNA for sequence analysis was isolated, and the source of the sampled individuals are indicated. The region of the promoter
corresponding to the upstream Sp1 site (Figure 1) was sequenced for Cercopithecus ascanius, Trachypithecus francoisi, Pygathrix nemaeus, and Lemur
catta (Figure 7A). For all other species and subspecies, the complete proximal and distal TNF promoter regions (21153 to +69 nt relative to the start
site of transcription) were sequenced.
doi:10.1371/journal.pone.0000621.g002
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plasy or lineage sorting inconsistent with the species tree due to
short intervals between subsequent speciation events, a point that
is important to consider in the context of human TNF promoter
SNP variant alleles, as will be discussed below.
We identified 332 fixed genetic differences (single nucleotide
changes, insertions, and deletions) in these primate TNF
promoters relative to the human sequence (Figure S1 and Table
S1). The fixed genetic differences are homozygous and invariant in
all representative individuals from a species or subspecies. A total
of 33 (,10%) fixed differences lie within 200 bp upstream of the
start site of transcription, that is, within the proximal core TNF
promoter region required for transcriptional activation of the TNF
gene in response to multiple stimuli. Of these, only 5 are found in
apes and only one occurs in the African apes: a G/T transversion
at position 29 [9], which is completely conserved in all non-
human primates examined (Figure S1 and Table S1). Notably, the
phylogenetic footprints from positions 2131 to 263 and 253 and
245 relative to the start site of TNF gene transcription [9] are
interrupted only by the 289 C/T transition in the vervet monkey
(Chlorocebus pygerythrus) and the 298 T/A transversion in the white-
headed capuchin (Cebus capucinus; Figure S1). We also identified 16
SNPs within specific primate species from apes, OWM, and NWM
representatives examined (Table S2).
Functional elements in mammalian gene promoters can be
identified by high conservation between species distantly related
on the evolutionary scale, particularly for genes with conserved
function across different taxa [44,45] . The proximal TNF
promoter shows high sequence conservation among primates,
with complete conservation within phylogenetic footprints across
seven primate species, including OWM and NWM [9]. Sequence
divergence among primate genomes is inherently low since
primates are relatively closely related on the evolutionary scale
among vertebrates. However, comparisons between gene se-
quences in primates can be considerably improved through the
technique of phylogenetic shadowing [46,47]. In order to
compensate for the relatively low level of sequence variation
among closely related species, this technique takes into account the
phylogenetic relationships among the set of species to be analyzed
and the rate at which mutations would be expected to accumulate
over time. Thus, rather than directly assessing the degree of
Figure 3. TNF promoter-based primate phylogenetic trees. Extended majority rule consensus trees derived from 1000 replications by bootstrap
analysis generated from a distance matrix between ,1.2 kb of sequence for each taxon using the Kimura 2-parameter model (A) and maximum
parsimony (B) is shown. Values at internodes indicate the number of times the group consisting of the species to the right of the internode occurred
among the trees (out of 1000 trees).
doi:10.1371/journal.pone.0000621.g003
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conservation among sequences, phylogenetic shadowing reveals
regions that have accumulated sequence variation at a relatively
slower rate, indicative of conserved function [46]. This can be
visualized as a conservation plot of the likelihood ratio that a given
nucleotide position experienced relatively faster or slower
accumulation of variation over time; the strongest peaks of the
conservation plot, that is, regions of low variation, are expected to
correlate with functional regions [47]. As shown in Figure 4, when
all of the primate TNF promoter sequences from this study are
analyzed by phylogenetic shadowing, the regions of lowest
variation lie within the proximal 200 base pairs involved in gene
activation and enhanceosome formation. These regions of low
variation also coincide with elements identified as functional
binding sites for transcription factors, which lie within the
proximal promoter (Figure 1). Although putative binding sites
for the NF-kB transcription factor lie outside of the proximal TNF
promoter, these do not coincide with the peaks in Figure 4, nor are
they conserved between human and mouse [48], consistent with
our previous studies demonstrating that the proximal ,200 base
pairs of the TNF promoter are sufficient for directing activation of
TNF gene transcription in response to multiple stimuli [1–4,6,48].
Thus, this analysis, which takes into account the evolutionary
relationships among the multiple primate species and subspecies
studied here, strongly corroborates the conclusion [9] that the
proximal TNF promoter is a highly conserved functional element.
Fixed differences in the TNF promoter distinguish
primate species and subspecies
In the primate species examined in this study, there are a total of
332 fixed differences between the positions corresponding to
21153 to +69 of the human TNF promoter region. Notably, we
found that 41 of these fixed differences can be used to distinguish
species and subspecies in primates, including the great apes
(Figure 5). For example, two fixed TNF promoter genetic
differences distinguish Pongo pygmaeus from Pongo abelii: the cytosine
residues present at positions2879 and 2861 in Pongo pygmaeus and
humans are a thymine and a single nucleotide deletion,
respectively, in Pongo abelii. In gorillas, five fixed differences at
positions 21112, 2770, 2521, 2518, and 2444 distinguish three
subspecies within the genus Gorilla: the western lowland gorilla (G.
g. gorilla) is marked by 2770 T/C and 2518 C/T; the eastern
lowland gorilla (G. beringei graueri), by 2770 T/C; and the
mountain gorilla (G. b. beringei), by 21112 G/T, 2521 C/T,
2518 C/T, and 2444 C/A. We note that we only have one
representative of G. beringei graueri and G. b. beringei because they are
critically endangered species; thus, we formally cannot rule out
that these sequence differences represent SNPs. A number of SNPs
were identified for Pan troglodytes, but no fixed differences occurred
among the four chimpanzee subspecies (Table S2). All four
subspecies of Pan troglodytes do contain a shared species-specific
fixed difference, however: a thymine at position 2667, where
a cytosine occurs in Pan paniscus and humans.
Multiple human TNF SNP variant alleles correspond
to divergent sequences in primates
Placing comparative sequence analysis of the TNF promoter from
multiple primate species in the context of known primate
phylogeny demonstrates that specific single nucleotide positions
are characteristic of different primate taxa (Figure 6). That is,
certain fixed genetic differences identified in this study are shared
Figure 4. Conservation of the proximal TNF promoter region in primates. Multiple sequence alignment (MSA) of the TNF promoter (21153 to
+69 nt relative to the start site of transcription) for human and all other primate species examined in this study using eShadow [47]. Nucleotide
position relative to the TNF start site of transcription is on the x-axis. Percentage variation (inversely proportional to conservation) is on the y-axis.
Peaks and valleys of the conservation plot correspond to regions of low and high variation, respectively, and 0% variation signifies 100% sequence
identity in the MSA. Black shading indicates regions of highest sequence conservation.
doi:10.1371/journal.pone.0000621.g004
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between humans and other primate clades. For example, some
fixed genetic differences are shared by species within the African
great ape clade, within the ape clade, or within the clade encom-
passing all apes and OWM (Table S3A), while others are com-
pletely conserved only within specific primate clades, for example,
NWM, OWM, gibbons, orangutans, and gorillas (Table S3B). By
placing these fixed differences in the context of evolutionary
relationships among primates, the ancestral nucleotide state of
these fixed differences can be deduced and we can estimate the
point at which a given fixed nucleotide difference diverged among
the primate taxa (Figure 6). Furthermore, it allows us to assess
which alleles of human TNF promoter SNPs at these positions are
identical to divergent sequences in the primate lineage, indicating
that a given allele in the human population has arisen either
directly (identical by descent) or independently (identical by state)
from primate ancestors. Strikingly, we found that distinct alleles of
a total of six human TNF promoter SNPs (2237 G/A, 2307 G/
A, 2375 G/A, 2862 C/A, 21030 T/C, and 21072 C/T) are
identical to an ancestral nucleotide in the primate lineage, and that
a seventh human SNP, 2856 C/T, is also a SNP in Pan paniscus.
As shown in Figure 6, the rare alleles of four human TNF
promoter SNPs (2307 G/A, 2862 C/A, 21072 C/T, and 2237
G/A) were detected as fixed sequence differences unique to
specific primate taxa. The rare allele of the 2307 G/A human
Figure 5. Fixed differences in the TNF promoter distinguish primate species and subspecies. Column headers indicate the position in the human
TNF promoter relative to the start site of transcription. The corresponding nucleotide sequence, deletion, or insertion for each species is indicated for
each row. Blue shading in a column indicates groups of primate subspecies within a species (or species within a genus) distinguished by a fixed
difference.
doi:10.1371/journal.pone.0000621.g005
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SNP, which has been identified as a fixed nucleotide in some
species of Old World monkeys [9,49], is present in all OWM
species studied here. This indicates that the adenine at position
2307 became fixed in the Cercopithecoidea superfamily (OWM)
at the point at which it diverged from the Hominoidea superfamily
(apes and humans) roughly 23–25 million years ago [39,41–
43,50,51], approximately at the geologic boundary between the
Oligocene and Miocene (23.3 million years ago) [52]. Similarly,
we detected the rare allele of the2862 C/A human SNP as a fixed
nucleotide in NWM of the Cebidae family, Cebus capucinus and the
common squirrel monkey (Saimiri sciureus), indicating that the
fixation of the adenine at position 2862 correlates with the
divergence of the Cebidae from common primate ancestors of the
NWM approximately 16–20 million years ago [53,54].
The rare allele of the 21072 C/T human SNP is present in all
gibbon species examined here, indicating that the thymine at
position 21072 was fixed in the gibbon lineage at a time
corresponding to the point of origin of the Hylobatidae, which is
roughly 15–19 million years ago [37,42,43,50,55]. Within the
Hylobatidae, we detected the rare allele of an additional human
SNP, 2237 G/A, as a fixed nucleotide difference only in
Symphalangus syndactylus. Four clades of gibbons, recently designated
as genera and distinguished by distinct diploid chromosome
number, are well established: Hylobates, Hoolock, Symphalangus, and
Nomascus [56,57]. Although most studies conclude that Hylobates
diverged most recently, comparative genomics analysis of nuclear
and mitochondrial DNA sequences has yielded conflicting models
of the phylogenetic relationships among the genera (for example,
see [58–60]) hindered by the unusually rapid chromosome
rearrangement rate in gibbons [61]. Thus, fixation of the adenine
at position 2237 in Symphalangus likely dates to a point in gibbon
evolution after the fixation of the thymine at position21072 and is
a derived condition in that clade.
In contrast to the other human TNF promoter SNPs described
above, the rare alleles of the 2375 G/A and 21030 T/C human
SNPs, rather than the common alleles, correspond to ancestral
Figure 6. Fixed differences in the TNF promoter mark primate ancestry. Clade diagram illustrating the basic and approximate evolutionary
relationships among the primate species in this study, with selected times of divergence (in millions of years) noted. Groups of fixed genetic
differences (the total number in parenthesis) completely conserved within clades are marked at the appropriate branch points (see Table S3). Human
TNF promoter SNPs which are ancestral in the primate lineage are listed. Ancestral sequences and transitions or transversions in the TNF promoter are
noted at the appropriate branchpoints.
doi:10.1371/journal.pone.0000621.g006
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nucleotide states in the primate lineage. As shown in Figure 6,
while the rare allele of the2307 G/A SNP became fixed in OWM
following their divergence from other primates ,25 million years
ago, the common allele of the2375 G/A SNP became fixed in the
rest of the Hominoidea superfamily (gibbons, great apes, and
humans), while the rare allele is present in all OWM and NWM.
In the case of the 21030 T/C human SNP, all primates except
for the Hominini tribe (the genus Pan and the genus Homo) bear
a cytosine, the rare allele in humans, as a fixed difference at
position 21030 in the TNF promoter, while Pan pansicus and Pan
troglodytes bear an adenine at position 21030. Thus, the Pan-
specific cytosine to adenine transversion at position 21030
appears to coincide with the divergence between the human-
chimpanzee clade and gorilla clade approximately 6–9 million
years ago [37,39,42,43,50,51], while the human-specific shift to
thymine appears to coincide with the human-chimpanzee split 5–7
million years ago [37,39,41–43,50,51,55,62] (Figure 6).
Notably, the sequence context of the ancestral cytosine at
position 21030 in the TNF promoter places it in a CpG
dinucleotide, which is particularly prone to mutation, as has been
observed in comparisons between the chimpanzee and human
genomes [63–66]. It is also interesting to note that in humans, the
21030 T/C SNP occurs in linkage with the 2862 C/A SNP
[16,19,29,67–69]. These linked 21030/2862 SNPs have been
shown to be in strong linkage with the B35 HLA haplotype, which
is associated with HIV susceptibility. Consistent with this, these
SNPs are thus associated with lack of control of HIV-1 viremia
[29], most likely due to this linkage [70]. Taken together these
associations suggest that the common thymine at the position in
humans was positively selected in a cassette of closely spaced genes.
Finally, one human TNF promoter SNP, 2856 C/T, is also
polymorphic in Pan paniscus, an unusual event since SNPs are
shared among great ape species at the expected neutral rate. For
example, a study of over 200 orthologues of human SNP sites in
Pan paniscus, Pan troglodytes, and Gorilla gorilla revealed only three
shared polymorphisms between humans and Pan pansicus and two
shared polymorphisms between humans and Gorilla gorilla; like the
2856 C/T SNP, all of these Pan paniscus SNPs (and one of the two
Gorilla gorilla SNPs) involved a CpG dinucleotide [63]. Such shared
polymorphisms may arise independently, which may be evidence
for stabilizing selection to maintain the SNP, or they may be
identical by descent [63]. Notably, this SNP is highly expressed in
human Amerindian populations, up to 45% in the Paez, and is in
linkage with Amerindian HLA haplotypes [19], suggesting that it
is a marker for a cassette of genes that are positively selected in
humans.
Fixed differences between Asian and African apes
affect stimulus-specific TNF gene activation
Fixed differences within or near the Sp1 site of the human TNF
promoter (59-CCCCGCCCCC-39) at 2172 to 2163 bp relative
to the start site of transcription are observed in representatives of
the Asian apes (Pongidae and Hylobatidae) and NWM, but not in
African great apes and OWM (Figure 7A). This site is one of two
functional Sp1 binding sites that have been characterized in the
human TNF promoter [3]. This particular Sp1 site is involved in
regulation of the human TNF gene in cells of the monocyte/
macrophage lineage in response to MTb infection and to
treatment with LPS but has no apparent role in TNF gene
regulation in T cells activated by calcium influx or by T cell
receptor ligands [1–4]. We thus speculated that these differences
may impact the regulation of these primate promoters in response
to stimulation of monocytes by LPS and MTb.
To test this hypothesis, we first assayed the ability of these
divergent Asian ape Sp1 sites to bind Sp1 proteins by performing
electrophoretic mobility shift assays (EMSAs) with nuclear extracts
from murine and human T cell lines and a monocytic murine cell
line. For this analysis we used oligonucleotides matching the
upstream Sp1 site of the two orangutan species and seven gibbon
species that represented all four genera of gibbon as probes and
compared their binding to that of an oligonucleotide matching the
human upstream Sp1 site (Figure 7B). Using specific antibodies,
we were able to examine the binding of Sp1 and Sp3 proteins,
which are highly conserved and ubiquitously expressed in murine
and human cell lines [71], to these sites. As shown in Figure 7B,
the 2168 G/A transition present in the Sp1 site in Pongo pygmaeus,
Pongo abelii, and Nomascus l. leucogenys strongly interferes with the
constitutive binding of Sp1 and Sp3 in T cells and monocytic cells
as compared to the binding of these proteins to the human Sp1 site
sequence. By contrast, the single 2161 C/T transition found in
Hylobates lar, Hoolock leuconedys, and Symphalangus syndactylus and the
single 2164 C/T transition found in Hylobates moloch, Hylobates
agilis, and Hylobates pileatus, which are outside of the predicted core
of the Sp1 site [3], does not inhibit binding of Sp1 and Sp3 to the
oligonucleotides matching these sites (Figure 7B).
To examine if impaired binding of Sp1 and Sp3 to these sites
impacted transcriptional regulation, we next prepared luciferase
reporters matching sequences from 2200 to +87 from Pongo,
Hylobates moloch, and Nomascus l. leucogenys. We also prepared a TNF-
luciferase reporter from Gorilla, which has an Sp1 site that is
identical to the human sequence but which varies from the human
proximal promoter sequence at position 29, and compared the
activation of all of these reporters to an isogenic human TNF
reporter construct [72]. Activation of the Pongo and Nomascus TNF
promoters was impaired up to 60% relative to the human
promoter in MTb-infected or LPS-treated monocytes but was not
affected in T cells treated with ionomycin (Figure 7C). In all cases,
transcriptional activation of the Gorilla TNF promoter was
essentially identical to that of the human TNF promoter,
indicating, in this context, that there is no functional role in
TNF gene transcription for the 29 G/T fixed difference found in
all non-human primates.
Thus, there is a strong correlation between transcription factor
binding at the upstream Sp1 site and transcriptional activation in
response to bacterial infection but not to calcium influx among
these primate TNF promoters. This is consistent with our previous
findings that Sp1 is recruited to the human TNF promoter and
required for its activation in response to LPS or MTb stimulation
in monocytic cells, but not for its activation in T cells in response
to calcium influx [1–4].
DISCUSSION
The identification of fixed genetic differences with functional
consequences, particularly those that underlie primate-specific and
especially human-specific adaptive changes, is perhaps the most
important goal of comparative primate genomics [44,73–80].
Global analysis of gene transcription through the use of
microarrays has revealed human-specific changes in gene
expression relative to other primates [81–85]. Several studies in
primates have also revealed human-specific changes within gene
coding regions, which may underlie the evolution of specific
human traits [45,76–80]. For example, fixed human differences in
the coding regions of the transcription factor FOXP2 and myosin
heavy chain genes have been linked to the evolutionary de-
velopment of speech in humans and the anatomy of the jaw,
respectively [86,87]. By contrast, humans have accumulated
mutations that disrupt genes encoding olfactory receptors at rates
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Figure 7. Functional analysis of fixed genetic differences in the upstream Sp1 site in primate TNF promoters. A. Sequence of the upstream Sp1
site in the TNF promoter from humans and the indicated non-human primates, with the horse (Equus caballus) and pig (Sus scrofa) sequences for
comparison. Nucleotide positions relative to the start site of TNF transcription are shown. B. EMSA of nuclear extracts from the indicated cell lines
incubated with radiolabeled oligonucleotides corresponding to the indicated primate TNF upstream Sp1 site. Positions of the Sp1- and Sp3-DNA
complexes, confirmed by antibody supershift assays (data not shown) are indicated. C. Transfections in the indicated cell lines with luciferase reporter
genes fused to the proximal TNF promoter (2200 to +87 nt) of the indicated primate species. Fold induction of luciferase activity in response to
treatment with ionomycin (I) in 68-41 T cells, treatment with lipopolysaccharide (LPS) in J774 monocytic cells, or infection with Mycobacterium
tuberculosis (MTb) in J774 monocytic cells is shown.
doi:10.1371/journal.pone.0000621.g007
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roughly fourfold higher than in the great apes and other primates
[88].
Although techniques like phylogenetic shadowing can be
applied toprimate gene sequences to identify putative regulatory
elements [9,46], human-specific changes in non-coding regions
have been more difficult to quantify than those in gene coding
regions, since the effect of a given nucleotide change in a putative
regulatory region cannot be readily deduced a priori. Despite the
power of comparative genomics and microarray analysis, quan-
tifying the effect of a given fixed genetic difference in a cis-
regulatory region upon transcriptional regulation has remained
elusive. Indeed, the transcriptional activity of human and
chimpanzee promoters in transient transfection gene reporter
assays does not always correlate with transcription profiles from
microarray data [89].
Although sequence divergence between humans and other
primates has been correlated with cis-regulatory regions known to
bind transcription factors, these studies did not identify or quantify
the binding of specific transcription factors [89–92]. In one study,
primate SNPs (rather than fixed differences) in the CCR5
promoter were shown alter the affinity of the transcription factor
NF-kB for its cognate DNA motif and have a modest effect upon
basal levels of CCR5 transcription [30]. Here, we combined the
strategies of comparative sequence analysis with biochemical
assays to examine a well-characterized cis-regulatory region, the
TNF promoter, in closely related primate species. By doing so, we
were able not only to reveal how fixed genetic differences in the
TNF promoter are markers of primate phylogeny, but also to
isolate fixed genetic differences in the Asian apes–relative to
humans and the African apes–that impact cell type- and stimulus-
specific regulation of the TNF gene.
The fixed genetic differences that we identify in this study are
particularly informative given the relative scarcity of divergent
sequences among primate species and because of the importance
of the gene in which they occur in the innate immune response.
For example, a recent study of multiple intergenic autosomal
regions in great apes and humans (16 to 22.4 kb) revealed no fixed
differences between Pongo pygmaeus and Pongo abelii [93], even
though Bornean and Sumatran orangutans are so divergent at the
nuclear and mitochondrial genome level that they have been
designated as distinct species [94–97].
Several TNF promoter SNPs are present in extended
haplotypes that mark human ethnic populations and human
ancestry [19]. For example, the 2243 A/G SNP is part of a sub-
Saharan African-derived extended haplotype, and the 2856 C/T
SNP is part of an Amerindian HLA haplotype [19]. Moreover, the
2307 G/A SNP, which is a marker of an extended haplotype in
European-derived populations [21] is not present in Amerindian
populations, while it occurs in ,10% of European-, Cambodian-,
and African-derived populations [19]. In this context it is striking
to consider that for the majority of SNPs in the human TNF
promoter, the complementary (common or the rare) allele, occurs
as a fixed difference in divergent primate clades.
A number of scenarios could explain why specific alleles of
human TNF promoter SNPs are identical to fixed nucleotides at
corresponding positions in primate TNF promoters. Moreover,
different scenarios could apply to specific nucleotide positions.
First, the variant SNP allele could represent the ancestral state by
descent. The allele could have reached fixation in the human
population due to genetic drift, or it might have appeared through
recent positive selection. Second, the variant SNP allele could
represent recent homoplasy, either through selection due to
certain constraints on promoter sequence patterns or due to
linkage with another genetic region, such as HLA.
Regardless of whether these variant human alleles are identical
to divergent sequences in the primate lineage by descent or are
identical by state, all of the nucleotide positions of these SNPs fall
outside the core region of the TNF promoter known to be critical
for TNF gene regulation. This observation is consistent with the
accumulation of mutations under neutral evolution, which in turn
may reflect linkage with other genes that have been positively
selected [9,20]. Indeed, since as described above, the majority of
human TNF promoter SNPs have been found to be in linkage
with HLA molecules [16,17,19,21], SNPs may also be in linkage
with other genes in the MHC locus with functional effects upon
resistance and susceptibility to infectious disease. Linkage of TNF
promoter SNPs with other genes is further supported by the fact
that, despite the statistical association of human TNF promoter
SNP alleles with clinical outcomes, attempts to determine a role
for these SNPs in TNF gene transcription have produced
inconsistent results, consistent with their location outside of the
core promoter region. Even for 2307 G/A, the most commonly
examined SNP in the human TNF promoter, studies comparing
the levels of TNF gene transcription (typically in response to LPS)
induced by the two alleles have reached conflicting conclusions
[24–26]. Linkage of SNPs at specific positions in the TNF
promoter with other genes in the MHC locus may in turn underlie
the fixation of specific nucleotides at these SNP positions and in
other regions outside of the core TNF promoter during the
evolution of the primate order.
Most notably, in addition to these fixed genetic differences outside
of the proximal TNF promoter, we have identified fixed genetic
differences in primate TNF promoters with direct impact upon TNF
gene transcription. These occur within a region corresponding to the
upstream Sp1 site (2173 to 2163 relative to the start site of
transcription) of the human TNF promoter (59-CCCCGCCCCC-
39), which is completely conserved in the African apes (Pan paniscus,
Pan troglodytes, and Gorilla). Fixed genetic differences are present in
Asian apes (59-CCCCACCCC-39 in both Pongo species and 59-
CCCCACCTC-39 in Nomascus l. leucogenys) that impair binding of
Sp1 proteins to the site and the transcriptional activity of the TNF
gene in a cell- and inducer- specific fashion. This recapitulates the
regulation of the human TNF promoter [1–7]; binding of Sp1
protein to the upstream Sp1 site in the human TNF promoter,
conserved in African ape TNF promoters, is required for induction
of TNF transcription in response to LPS and MTb, but not for its
expression in activated T cells [2–4].
Fixed genetic differences within or downstream of the upstream
Sp1 site also occur in the gibbons, the other Asian apes examined in
this study, although the exact nucleotide sequence varies even within
the Hylobates genus (see Figures 1, 7A, and 7B). Variation at the
upstream Sp1 site in the TNF promoter does not occur along
geographic lines across all primate families, however: in all species of
the Cercopithecidae (OWM) family examined in this study,
including those native to Asia [Francois’ langur (Trachypithecus
francoisi) and the red-shanked douc (Pygathrix nemaeus)], the upstream
Sp1 site is identical to the human sequence (see Figure 7A).
It is intriguing to speculate that the environmental conditions,
perhaps consisting of novel pathogens that confronted the
diverging populations derived from a common ancestor of Old
World monkeys and the small and great apes, provided selective
pressure on the TNF promoter locus. As subsequent evolution and
speciation events proceeded, nucleotides involved in induction of
TNF gene expression in response to bacterial infection (LPS or
MTb) of monocytic cells, rather than activation of T cells, became
fixed in the gibbon-orangutan and the African great ape clades.
For orangutans and gibbons, the considerable geographic flux of
the Malay Archipelago region of southeast Asia over millions of
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years, alternately isolating and reuniting local animal populations
in the course of their adaptation and speciation [96], may have
contributed to fixed genetic differences at the upstream Sp1 site of
the TNF promoter. Indeed, based on comparisons between
human and chimpanzee genome sequences, positive selection has
been proposed to have a greater influence in 59 untranslated
regions as compared to protein coding regions [98]. Furthermore,
co-evolution between hosts and pathogens has been proposed for
primates and certain viruses and parasites [99,100]; such re-
ciprocal changes within a specific disease environment may have
also influenced geographically dependent fixed differences in the
primate TNF promoter. Finally, in addition to their direct
functional effect upon TNF transcription, the Asian ape- and
African ape-specific TNF promoter alleles may reflect linkage
disequilibrium with neighboring genes that were under selective
evolutionary pressure.
As genomic sequence data is acquired for different primate
species, including data for extinct species such as Homo
neanderthalensis [101,102], we expect that other functional genetic
changes marking points of divergence and speciation among the
primate lineages will be discovered, contributing new insights into
the genetic basis of the development of human and primate
phenotypes. It will also be of interest to integrate information from
primate comparative genomics with data on genetic differences
among humans as these accumulate [103,104]. Furthermore,
given that multiple primate species in this study are endangered–
Gorilla beringei beringei, Gorilla beringei graueri, and Pongo abelii are
among the 25 most endangered primate species in the world
[105]–our results underscore the importance of primate conser-
vation in understanding the evolution and development of key
genes in the human immune response.
MATERIALS AND METHODS
Primate samples
Cell lines and samples of blood or DNA from representative
individuals were obtained for the primate species and subspecies as
described in Figure 2. To confirm the subspecies of chimpanzees,
we amplified 498 bp of the mitochondrial D-loop region (control
region) corresponding to the positions 15,998–16,497. PCR
products were sequenced and these sequences were analyzed
together with a representative of each of the subspecies reported in
GenBank (Pan troglodytes troglodytes, AF102683; P. t. schweinfurthii,
AF102687; P. t. verus, AF315499; P. t. vellerosus, AF315498) on
a phylogenetic tree using maximum likelihood methods with
PHYLIP 3.65 package [106]. Samples associating in a clear cluster
with a reference subspecies sequence were assigned to that
subspecies, as described previously [107]. DNA from orangutans
was obtained from cell lines described previously [93,95].
Sequencing of primate TNF promoters
Genomic DNA was isolated from whole blood using the QIAamp
DNA Blood kit (Qiagen). The TNF promoter was amplified using
the following primer sets: for human, apes, and OWM, TNF-F1
(59-AGT GAG AAC TTC CCA GTC TAT CTA AG-39) and
TNF-R1 (59-CCG TGG GTC AGT ATG TGA GA-39) [19]; for
NWM and lemur, TNF-F2 (59-CCC AAT AAA CCT CTT TTC
TCT GA-39), TNF-F3 (59-TTG GAA GCC AAG ACT GAA
ACC-39) and TNF-R2 (59-GTG CCA ACA ACT GCC TTT A-
39). In the case of samples for which just one individual was
available, the PCR product was subcloned into the p-GEM-T easy
vector (Promega) and at least 3 colonies were analyzed. Sequences
were obtained from both directions from 21153 to +69 using
a Perkin-Elmer 377 automatic sequencer.
Plasmids
Using PCR, we amplified primate TNF promoters from 2200 to
+87 nt relative to the transcription start site and the NheI-BglII
restriction fragment was subcloned into pGL3 Basic (Promega)
and sequenced. Constructs for transient transfection were thus
isogenic to the human 2200 TNF-Luc reporter [72]. Plasmids
were isolated with EndoFree plasmid kits (Qiagen) for use in the
J774A.1 cell line and Maxiprep plasmid kits (Promega) for Jurkat
and 68-41 cell lines.
Cell culture and Transfection
The Jurkat T cell line (ATCC) and T cell hybridoma 68-41(a gift
from Masato Kubo, Science University of Tokyo, Tokyo, Japan)
were maintained at 37uC, 5% CO2, in RPMI 1640 (Gibco)
supplemented with penicillin, streptomycin, 10% fetal bovine
serum, and 2mM L-glutamine. Transfections were performed
using DEAE-Dextran as described [5]. After 6 hours, cells were
stimulated with 1 mM Ionomycin (Calbiochem) for approximately
16 hours. The J774A.1 Monocyte cell line (ATCC) was main-
tained at 37uC, 5% CO2 in Dulbecco’s MEM media (Gibco)
suplemented with penicillin, streptomycin, 10% fetal bovine
serum. Transfections were performed using FuGene6 (Roche)
using a 3:2 ratio (pGL3: pR-TK Renilla) according to the
manufacturer’s protocol. Eight hours after transfection, cells were
treated with 2 mg/ml of LPS (0111:B4, Sigma) or 5 mg/ml of
H37Rv whole sonicate of M. tuberculosis (a gift from Chris Dascher
at Brigham and Women’s Hospital, Boston MA, USA) and
harvested 16 hours later. Luciferase assays were performed
according to the manufacturer’s instructions (Dual Luciferase
Reporter Assay System; Promega) using a Dynex luminometer,
with Renilla luciferace (pR-TK) as an internal control.
Electrophoretic Mobility Shift Assay
Nuclear extracts were prepared from Jurkat and 68-41 cell lines
after stimulation for 2 hours with ionomycin, and from J774A.1
cells after stimulation for 2 hours with LPS or M. tuberculosis as
described above. Nuclear extracts were prepared, and electropho-
retic mobility shift assays were performed, as previously described
[5]. Sp1 sense and anti-sense oligonucleotide probe sequences
were as follows: human, 59-AAA TCC CCG CCC CCG CGA
TGG-39 and 59-CCA TCG CGG GGG CGG GGA TTT-39;
Gorilla, 59-AAA TCC CCG CCC CCG CGA TGG-39 and 59-
CCA TCG CGG GGG CGG GGA TTT-39; Pongo, 59-AAA TCC
CCA CCC CCG TGA TGG-39 and 59-CCA TCA CGG GGG
TGG GGA TTT-39; Hylobates moloch, 59-AAA TCC CCG CCC
CCG TGA TGG-39 and 59-CCA TCA CGG GGG CGG GGA
TTT-39; Hoolock leuconedys, 59-AAA TCC CCG CCC TCG CGA
TGG-39 and 59-CCA TCG CGA GGG CGG GGA TTT-39;
Nomascus l. leucogenys, 59-AAA TCC CCA CCC TCG CGA TGG-
39 and 59-CCA TCG CGA GGG TGG GGA TTT-39.
Phylogenetic and Statistical analysis
The sequences were aligned with the CLUSTALW program,
version 1.7 [108]. Phylogenetic analyses were performed using the
PHYLIP v. 3.57c program [106]. First, a matrix of distances were
obtained using the Kimura 2-parameter model, and then we
generated 1000 replications by bootstrap analysis. Phylogenetic
trees were generated using Neighbor-joining, and a consensus tree
was finally obtained. We generated a second set of bootstrap
values using heuristic parsimony with the PAUP v.3.1 program
[109]. Phylogenetic shadowing of the TNF promoter was
performed using the eShadow program [47]. The MSA plot was
generated using TNF promoter sequences 21153 to +69 from
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human and all other primate species examined in the studies with
a sliding window of 50 nt. Maximum variation was 10%, minimal
length 80 nt.
SUPPORTING INFORMATION
Figure S1 Complete alignment of the TNF promoter sequences
from primate species used in this study. Numbering corresponds to
the human TNF promoter sequence, 21153 to +69 nt relative to
the start site of transcription, shown at the top. Species and
subspecies are indicated, along with nucleotide changes, conserved
positions (.), and deletions (2). All alterations from the human
sequence represent fixed differences, except positions in which
SNPs were detected in 40% or more of the individuals examined,
which are denoted R (A or G), Y (C or T), M (A or C), or S (C or
G). The21027 to21029 deletion found as a SNP in P. t. troglodytes
is also shown. On the human TNF promoter sequence, positions
of human SNPs and every hundredth base pair position are in
boldface, and every tenth base pair position is underlined.
Found at: doi:10.1371/journal.pone.0000621.s001 (0.15 MB
DOC)
Table S1 Total fixed differences among the primate TNF
promoters. Positions of single nucleotide changes and discrete
insertions or deletions, relative to the consensus human TNF
promoter sequence, observed in this study are shown.
Found at: doi:10.1371/journal.pone.0000621.s002 (0.04 MB
PDF)
Table S2 SNPs in primate TNF promoters. For each of the
indicated species or subspecies, the position, sequence change, and
frequency (in the total number of individuals examined) of each
SNP detected in the TNF promoter is shown. SNPs in which the
wild type allele corresponds to the sequence found in the other
subspecies of a given species are shown, while the mutant alleles
that correspond to the human sequence are noted with an asterisk.
Found at: doi:10.1371/journal.pone.0000621.s003 (0.07 MB
PDF)
Table S3 Fixed differences in the TNF promoter that mark
primate clades. Total fixed genetic differences in the TNF
promoter that are unique to and that are completely conserved
within the indicated primate taxa are shown. A. For each position,
the sequence found within and outside of the indicated clades is
shown. B. For each position, the sequence found in humans and in
the indicated genus or clade is shown. The Cebidae family
includes Cebus capucinus and Saimiri sciureus; the Atelinae subfamily,
Ateles geoffroyi and Lagothrix lagotricha. See Figure 6 for diagram of
evolutionary context.
Found at: doi:10.1371/journal.pone.0000621.s004 (0.03 MB
PDF)
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